Literature DB >> 33466589

Significance of NETs Formation in COVID-19.

Karolina Janiuk1, Ewa Jabłońska1, Marzena Garley1.   

Abstract

Severe contagious respiratory disease-COVID-19-caused by the SARS-CoV-2 coronavirus, can lead to fatal respiratory failure associated with an excessive inflammatory response. Infiltration and spread of SARS-CoV-2 are based on the interaction between the virus' structural protein S and the cell's receptor-angiotensin-converting enzyme 2 (ACE2), with the simultaneous involvement of human trans-membrane protease, serine 2 (TMPRSS2). Many scientific reports stress the importance of elevated recruitment and activity of neutrophils, which can form extracellular neutrophil traps (NETs) playing a significant role in the mechanism of combating pathogens, in the pathogenesis of COVID-19. Excessive generation of NETs during prolonged periods of inflammation predisposes for the occurrence of undesirable reactions including thromboembolic complications and damage to surrounding tissues and organs. Within the present manuscript, we draw attention to the impact of NET generation on the severe course of COVID-19 in patients with concurrent cardiovascular and metabolic diseases. Additionally, we indicate the necessity to explore not only the cellular but also the molecular bases of COVID-19 pathogenesis, which may aid the development of dedicated therapies meant to improve chances for the successful treatment of patients. We also present new directions of research into medications that display NETs formation regulatory properties as potential significant therapeutic strategies in the progress of COVID-19.

Entities:  

Keywords:  COVID-19; NETs; SARS-CoV-1; neutrophils

Mesh:

Year:  2021        PMID: 33466589      PMCID: PMC7828704          DOI: 10.3390/cells10010151

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  70 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.

Authors:  Bhawna Tomar; Hans-Joachim Anders; Jyaysi Desai; Shrikant R Mulay
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

Review 3.  Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.

Authors:  Sebastiano Cicco; Gerolamo Cicco; Vito Racanelli; Angelo Vacca
Journal:  Mediators Inflamm       Date:  2020-07-16       Impact factor: 4.711

4.  Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.

Authors:  Wenjun Wang; Xiaoqing Liu; Sipei Wu; Sibei Chen; Yimin Li; Lingbo Nong; Puyi Lie; Liyan Huang; Linling Cheng; Yongping Lin; Jianxing He
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

5.  Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.

Authors:  Tobias Herold; Vindi Jurinovic; Chiara Arnreich; Brian J Lipworth; Johannes C Hellmuth; Michael von Bergwelt-Baildon; Matthias Klein; Tobias Weinberger
Journal:  J Allergy Clin Immunol       Date:  2020-05-18       Impact factor: 10.793

6.  Immunothrombosis in severe COVID-19.

Authors:  Daigo Nakazawa; Akihiro Ishizu
Journal:  EBioMedicine       Date:  2020-08-15       Impact factor: 8.143

7.  Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Authors:  Canrong Wu; Yang Liu; Yueying Yang; Peng Zhang; Wu Zhong; Yali Wang; Qiqi Wang; Yang Xu; Mingxue Li; Xingzhou Li; Mengzhu Zheng; Lixia Chen; Hua Li
Journal:  Acta Pharm Sin B       Date:  2020-02-27       Impact factor: 11.413

8.  Neutrophil extracellular traps and thrombosis in COVID-19.

Authors:  Yu Zuo; Melanie Zuo; Srilakshmi Yalavarthi; Kelsey Gockman; Jacqueline A Madison; Hui Shi; Wrenn Woodard; Sean P Lezak; Njira L Lugogo; Jason S Knight; Yogendra Kanthi
Journal:  J Thromb Thrombolysis       Date:  2020-11-05       Impact factor: 2.300

9.  Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19.

Authors:  Coraline Radermecker; Nancy Detrembleur; Julien Guiot; Etienne Cavalier; Monique Henket; Céline d'Emal; Céline Vanwinge; Didier Cataldo; Cécile Oury; Philippe Delvenne; Thomas Marichal
Journal:  J Exp Med       Date:  2020-12-07       Impact factor: 14.307

10.  Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients.

Authors:  Bingwen Eugene Fan; Thirugnanam Umapathi; Karen Chua; Yew Woon Chia; Shiun Woei Wong; Glenn Wei Leong Tan; Sadhana Chandrasekar; Ying Hui Lum; Shawn Vasoo; Rinkoo Dalan
Journal:  J Thromb Thrombolysis       Date:  2020-11-07       Impact factor: 2.300

View more
  22 in total

1.  Neutrophilic inflammation promotes SARS-CoV-2 infectivity and augments the inflammatory responses in airway epithelial cells.

Authors:  B A Calvert; E J Quiroz; Z Lorenzana; N Doan; S Kim; C N Senger; W D Wallace; M P Salomon; J Henley; A L Ryan
Journal:  bioRxiv       Date:  2022-06-06

2.  Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent.

Authors:  Udaya S Tantry; Karsten Schror; Eliano Pio Navarese; Young-Hoon Jeong; Jacek Kubica; Kevin P Bliden; Paul A Gurbel
Journal:  J Exp Pharmacol       Date:  2021-12-07

Review 3.  NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.

Authors:  Yuanfeng Zhu; Xiaoli Chen; Xin Liu
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

Review 4.  Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review.

Authors:  Areez Shafqat; Shameel Shafqat; Sulaiman Al Salameh; Junaid Kashir; Khaled Alkattan; Ahmed Yaqinuddin
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

Review 5.  Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.

Authors:  Brandon Bautista-Becerril; Rebeca Campi-Caballero; Samuel Sevilla-Fuentes; Laura M Hernández-Regino; Alejandro Hanono; Al Flores-Bustamante; Julieta González-Flores; Carlos A García-Ávila; Arnoldo Aquino-Gálvez; Manuel Castillejos-López; Armida Juárez-Cisneros; Angel Camarena
Journal:  Biomolecules       Date:  2021-05-06

Review 6.  Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

Authors:  Joshua R Cook; John Ausiello
Journal:  Rev Endocr Metab Disord       Date:  2021-07-01       Impact factor: 9.306

Review 7.  Corticosteroid treatment for acute/acute-on-chronic experimental and naturally occurring pancreatitis in several species: a scoping review to inform possible use in dogs.

Authors:  Kari-Anne Bjørnkjær-Nielsen; Charlotte Reinhard Bjørnvad
Journal:  Acta Vet Scand       Date:  2021-07-13       Impact factor: 1.695

Review 8.  Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

9.  Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine.

Authors:  Jules Russick; Pierre-Emmanuel Foy; Nathalie Josseaume; Maxime Meylan; Nadine Ben Hamouda; Amos Kirilovsky; Carine El Sissy; Eric Tartour; David M Smadja; Alexandre Karras; Jean-Sébastien Hulot; Marine Livrozet; Antoine Fayol; Jean-Benoit Arlet; Jean-Luc Diehl; Marie-Agnès Dragon-Durey; Franck Pagès; Isabelle Cremer
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

10.  Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Bettina Hohberger; Marion Ganslmayer; Marianna Lucio; Friedrich Kruse; Jakob Hoffmanns; Michael Moritz; Lennart Rogge; Felix Heltmann; Charlotte Szewczykowski; Julia Fürst; Maximilian Raftis; Antonio Bergua; Matthias Zenkel; Andreas Gießl; Ursula Schlötzer-Schrehardt; Paul Lehmann; Richard Strauß; Christian Mardin; Martin Herrmann
Journal:  Front Med (Lausanne)       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.